KRAS Mutational Regression Is Associated With Oligo-Metastatic Status and Good Prognosis in Metastatic Colorectal Cancer
Sign Up to like & getrecommendations! Published in 2021 at "Frontiers in Oncology"
DOI: 10.3389/fonc.2021.632962
Abstract: Background We previously reported that loss of KRAS mutations (“regressive” mutational trajectories) from primary tumors to metastases associated with the oligo-metastatic status in colorectal cancer (CRC). The present study was undertaken in order to analyze… read more here.
Keywords: oligo metastatic; metastatic status; colorectal cancer; associated oligo ... See more keywords
Non-Invasive and Real-Time Monitoring of the Breast Cancer Metastasis Degree via Metabolomics
Sign Up to like & getrecommendations! Published in 2022 at "Cancers"
DOI: 10.3390/cancers14225589
Abstract: Simple Summary Breast cancer (BC) is a serious threat to women’s health and metastasis is the major cause of BC-associated mortality. Failure to detect and remove occult micrometastases limits the control of tumor recurrences. More… read more here.
Keywords: metastasis; non invasive; breast cancer; tumor ... See more keywords
Impact of metastatic status on the prognosis of EGFR mutation-positive non-small cell lung cancer patients treated with first-generation EGFR-tyrosine kinase inhibitors.
Sign Up to like & getrecommendations! Published in 2017 at "Oncology letters"
DOI: 10.3892/ol.2017.7125
Abstract: The aim of the present study was to analyze the impact of metastatic status on the prognosis of epithelial growth factor receptor (EGFR) mutation-positive patients with non-small cell lung cancer (NSCLC) treated with first-generation EGFR-tyrosine… read more here.
Keywords: metastatic status; mutation positive; treated first; egfr mutation ... See more keywords